These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26108365)

  • 41. Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: a tissue Doppler study in echocardiographic practice.
    Cuspidi C; Negri F; Sala C; Valerio C; Mancia G
    Blood Press; 2012 Feb; 21(1):24-30. PubMed ID: 21992028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is echo-determined left ventricular geometry associated with ventricular filling and midwall shortening in hypertensive ventricular hypertrophy?
    Palmiero P; Maiello M; Nanda NC
    Echocardiography; 2008 Jan; 25(1):20-6. PubMed ID: 18186776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between impaired elastic properties of aorta with left ventricle geometric patterns and left ventricle diastolic functions in patients with newly diagnosed essential hypertension.
    Gur M; Yilmaz R; Demirbag R; Yildiz A; Menduh Bas M; Polat M
    Int J Clin Pract; 2006 Nov; 60(11):1357-63. PubMed ID: 17073833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
    Palmieri V; Wachtell K; Gerdts E; Bella JN; Papademetriou V; Tuxen C; Nieminen MS; Dahlöf B; de Simone G; Devereux RB
    Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The assessment of relationship between left ventricular geometry and microvolt T-wave alternans in sustained hypertension.
    Surgit O; Erturk M; Buturak A; Akgul O; Pusuroglu H; Cakmak HA; Yazan S; Gul M; Akkaya E; Eksik A
    Blood Press; 2014 Dec; 23(6):349-55. PubMed ID: 24919782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S; Sciarretta S; Ciavarella GM; Venturelli V; De Paolis P; Tocci G; De Biase L; Ferrucci A; Volpe M
    J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Left ventricular mass but not geometry determines left atrial size in the early stages of hypertension.
    Tsioufis C; Taxiarchou E; Syrseloudis D; Chatzis D; Tsiachris D; Chatzistamatiou E; Skiadas I; Metallinos G; Tsiamis E; Stefanadis C
    J Hum Hypertens; 2009 Oct; 23(10):674-9. PubMed ID: 19262582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome.
    Celic V; Majstorovic A; Pencic-Popovic B; Sljivic A; Lopez-Andres N; Roy I; Escribano E; Beunza M; Melero A; Floridi F; Magrini L; Marino R; Salerno G; Cardelli P; Di Somma S
    Ann Lab Med; 2016 Nov; 36(6):542-9. PubMed ID: 27578507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors?
    Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Imai M; Kiyomoto H; Nishiyama A; Kohno M
    Clin Exp Hypertens; 2010 Jan; 32(2):113-20. PubMed ID: 20374184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age related prevalence of severe left ventricular hypertrophy in essential hypertension: echocardiographic findings from the ETODH study.
    Cuspidi C; Meani S; Sala C; Valerio C; Negri F; Mancia G
    Blood Press; 2012 Jun; 21(3):139-45. PubMed ID: 22416806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Refined 4-group classification of left ventricular hypertrophy based on ventricular concentricity and volume dilatation outlines distinct noninvasive hemodynamic profiles in a large contemporary echocardiographic population.
    Barbieri A; Rossi A; Gaibazzi N; Erlicher A; Mureddu GF; Frattini S; Faden G; Manicardi M; Beraldi M; Agostini F; Lazzarini V; Moreo A; Temporelli PL; Faggiano P
    Echocardiography; 2018 Sep; 35(9):1258-1265. PubMed ID: 29797430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and determinants of left ventricular geometric abnormalities in hypertensive patients: A study based on the updated classification system of left ventricular geometry.
    Sha T; Huang YQ; Cai AP; Huang C; Zhang Y; Chen JY; Zhou YL; Yu XJ; Zhou D; Tang ST; Feng YQ; Tan N
    Hellenic J Cardiol; 2017; 58(2):124-132. PubMed ID: 28179146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Refining the classification of left ventricular hypertrophy to provide new insights into the progression from hypertension to heart failure.
    Garg S; Drazner MH
    Curr Opin Cardiol; 2016 Jul; 31(4):387-93. PubMed ID: 27168169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association of metabolic syndrome with left ventricular mass and geometry in community-based hypertensive patients among Han Chinese.
    Wang S; Song K; Guo X; Xue H; Wang N; Chen J; Zou Y; Sun K; Wang H; He J; Hui R
    J Res Med Sci; 2015 Oct; 20(10):963-8. PubMed ID: 26929761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimate of ischemic stroke prevalence according to a novel 4-tiered classification of left ventricular hypertrophy: insights from the general Chinese population.
    Wang H; Wang S; Yi X; Tao Y; Qian H; Jia P; Chen Y; Sun Y
    Ann Med; 2018 Sep; 50(6):519-528. PubMed ID: 30001637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Association between metabolic syndrome and incidence of atrial fibrillation in essential hypertensive patients without left ventricular hypertrophy].
    Liu HL; Lu XL; Guo ZP; Lin JX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jan; 38(1):15-9. PubMed ID: 20398481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence, clinical characteristics and echocardiography parameters of non-resistant, resistant and refractory hypertension in Chinese.
    Cao G; Chen C; Lin Q; Chen Y; Zhen Z; Zou Y; Liu J; Wu M; Wang R; Liu M; Zhao C; Lu S; Ng MY; Tse HF; Yiu KH
    Postgrad Med; 2017 Mar; 129(2):187-192. PubMed ID: 27960613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Which definition for echocardiographic left ventricular hypertrophy?
    Abergel E; Tase M; Bohlender J; Menard J; Chatellier G
    Am J Cardiol; 1995 Mar; 75(7):498-502. PubMed ID: 7863997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of left ventricular mass and geometric remodeling in treated and untreated men and women >50 years of age with systemic hypertension.
    Zabalgoitia M; Rahman SN; Haley WE; Amerena J; Krause L; Oneschuk L; Yarows S; Yunis C; Lucas C
    Am J Cardiol; 1997 Sep; 80(5):648-51. PubMed ID: 9295003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Left ventricular hypertrophy as a marker of adverse cardiovascular risk in persons of various age groups].
    Barsukov AV; Glukhovskoĭ DV; Zobnina MP; Mirokhina MA; Dydyshko VT; Vasil'ev VN; Kitsyshin VP; Tishko VV
    Adv Gerontol; 2014; 27(4):763-70. PubMed ID: 25946857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.